Jyong Biotech MENS
NASDAQ MENS
$1.89 +0.03 (+1.61%)
At close: Oct 21, 2026 · 4:00 PM EDT

Jyong Biotech (MENS) Enterprise Value (2025)

Updated

Jyong Biotech (MENS) recorded Enterprise Value of $299.13 million in the quarter ended Dec 31, 2025.

Analysis

Jyong Biotech (MENS) Enterprise Value (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Jyong Biotech 137.99 Mn 137.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 299.13 Mn
Jun 30, 2025 606.56 Mn
API Access

Jyong Biotech Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=MENS&period=max&api_key=YOUR_API_KEY